Despite the promising outlook, the hyperthermia treatment market faces several challenges. High costs associated with advanced hyperthermia equipment, the need for specialized training for healthcare providers, and limited availability in some regions are significant barriers to market growth. Moreover, the lack of widespread clinical acceptance and reimbursement issues in certain countries may hinder the adoption of hyperthermia treatments. Addressing these challenges through strategic partnerships, education, and increased investment in research and development will be crucial for the market’s sustained growth.